Oricell Therapeutics
Develops next-generation cell therapies for oncology and immunology
$110MPre-IPO
Role not disclosedLoading investors…
Activity from announced rounds
Develops next-generation cell therapies for oncology and immunology
Develops next-generation cell therapies for oncology and immunology